Welcome back to another insightful episode of the Oncology Brothers podcast! In this episode, hosts Rahul and Rohit Gosain are joined by Dr. Caitlin Costello, an associate professor and expert in multiple myeloma from UC San Diego. The conversation focuses on tips for optimizing multiple myeloma care, covering critical aspects like diagnostic workup, evolving treatment strategies, and the growing role of minimal residual disease (MRD) in patient monitoring.
Dr. Costello shares essential insights on the initial workup needed before beginning treatment for newly diagnosed multiple myeloma, stressing the value of advanced imaging techniques and the use of specific biomarkers to assess risk. The discussion also delves into personalized treatment approaches for both transplant-eligible and transplant-ineligible patients, along with considerations for maintenance therapy based on risk profiles.
Key strategies are explored in detail, including the role of quadruplet therapy, the importance of achieving MRD negativity, and approaches for managing high-risk myeloma patients. Dr. Costello also provides practical tips for community oncologists, highlighting the importance of regular biomarker monitoring and implementing prophylactic measures to improve patient outcomes.
Tune in to this valuable episode for expert tips on optimizing multiple myeloma care and stay updated with the latest advancements in the field. Don’t forget to subscribe to the Oncology Brothers podcast for ongoing insights into hematology oncology and to stay informed on the best practices for multiple myeloma treatment.
Full Podcast: [ Ссылка ]
Subscribe Onc Brothers: @oncologybrothers
Website: [ Ссылка ]
Twitter: [ Ссылка ]
Contact us at info@oncbrothers.com
